Craft

InspireMD

Stock Price

$2.5

2024-10-29

Market Capitalization

$63 M

2024-10-29

Revenue

$9 M

FY, 2025

InspireMD Summary

Company Summary

Overview
InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
Type
Public
Status
Active
Founded
2005
HQ
Tel Aviv-Yafo, IL | view all locations
Website
http://www.inspiremd.com/
Cybersecurity rating
Sectors

Key People

  • Marvin Slosman

    Marvin Slosman, Chief Executive Officer, Director

  • Paul Stuka

    Paul Stuka, Chairman of the Board

  • Craig Shore

    Craig Shore, Chief Financial Officer

  • Michael Berman

    Michael Berman, Director

    LocationsView all

    2 locations detected

    • Tel Aviv-Yafo, Tel Aviv District HQ

      Israel

      4 Menorat HaMa'or St

    • Winsen (Luhe), Niedersachsen

      Germany

      16 Boschstraße

    InspireMD Financials

    Summary Financials

    Revenue (Q1, 2026)
    $3.4M
    Gross profit (Q1, 2026)
    $687.0K
    Net income (Q1, 2026)
    ($13.7M)
    Cash (Q1, 2026)
    $11.4M
    EBIT (Q1, 2026)
    ($14.0M)
    Enterprise value
    $53.7M

    Footer menu